European Academy of Allergy and Clinical Immunology

What European Academy of Allergy and Clinical Immunology does

EAACI (European Academy of Allergy and Clinical Immunology) is a Zurich-based non-profit professional medical association founded in 1956 in Florence and re-established under its current name in 1971. It serves more than 20,000 members (clinicians, researchers, and allied health professionals) across 142+ countries and coordinates with 54+ affiliated National Allergy Societies through a NAIS Committee. The organisation positions itself as the primary European reference body in allergy and clinical immunology, structured around 7 Sections (Asthma, Pediatrics, Dermatology, ENT, Basic & Clinical Immunology, Allied Health & Primary Care, JM Assembly) with multiple Interest Groups and Working Groups spanning food allergy, allergen immunotherapy, biologicals, mast cell diseases, and related disciplines.

Its core offering is a platform-plus-events model: flagship Annual Congresses (Istanbul 2026, prior London 2010 congress held 7,989 delegates; 2020 first digital congress served 8,000+ delegates), Focused Meetings (FAAM-EUROBAT-ISMA 2026 in Utrecht, SAM 2027 in Paris), Allergy and Winter Schools, plus the EAACI/UEMS Knowledge Exam administered online via ProctorU. Digital products include the EAACI Nexus learning platform, EAACI Knowledge Hub, MyEAACI member portal, virtual congress platform, and the EAACI Events mobile app. Journals (Allergy, Pediatric Allergy and Immunology, Clinical and Translational Allergy) are published in partnership with Wiley. Educational, fellowship, mentorship, and JM Quiz programmes target Junior Members, while the EAACI 3H Initiative integrates Research & Innovation, Public/Patients/Outreach, and Knowledge Hubs.

EAACI is funded by annual membership fees, event registrations, congress sponsorship and exhibitor revenue (including 16 founder sponsors at the Istanbul 2026 congress: ALK, AstraZeneca, Novartis, Sanofi Regeneron, GSK, Takeda, CSL, Stallergenes Greer, DBV Technologies, Blueprint Medicines, Celltrion, HAL Allergy, LETI Pharma, Neopharmed Gentili, Allergopharma, Allergy Therapeutics), Knowledge Exam fees, and journal publishing income. The organisation is governed by a 2026-2028 Executive Committee headed by President Mohamed Shamji and Secretary General María Escribese, operating under Swiss law with headquarters in Zurich (Hagenholzstrasse 111, established 2009) and an EU liaison office opened in 2014.

Name

European Academy of Allergy and Clinical Immunology

Legal name

European Academy of Allergy and Clinical Immunology

Website

https://eaaci.org

Company type

Private

Founded year

1956

Operating status

Operating

Headcount range

11–50 employees

Short description

EAACI is a Zurich-based non-profit medical association serving 20,000+ allergy and clinical immunology professionals across 142+ countries. It delivers congresses, focused meetings, peer-reviewed journals, the EAACI/UEMS Knowledge Exam, and digital learning platforms including EAACI Nexus and Knowledge Hub.

Ownership category

akta.pro rank

Headquarters

HQ city

Zürich

HQ country

Switzerland

HQ region

Europe

Offices6 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Membership Fees: EAACI operates as a membership-based professional association. Membership categories include regular members, Junior Members, and affiliates. Members receive access to journals, educational resources, discounted event registration, and professional networking opportunities
2. Event Registration: Revenue from registration fees for Annual Congress, Focused Meetings, Allergy Schools, Winter Schools, and other EAACI events. Registration categories include regular participants, students, speakers, media representatives, and exhibitors. Member rates are discounted
3. EAACI/UEMS Knowledge Exam: Annual certification exam in allergology and clinical immunology. Candidates pay registration and examination fees
4. Sponsorship and Exhibitor Revenue: Corporate sponsorship of congresses and events. The EAACI Annual Congress 2026 lists 16 founder sponsors including ALK, Allergopharma, Allergy Therapeutics, AstraZeneca, CSL, Novartis, Sanofi Regeneron, Stallergenes Greer, DBV Technologies, GSK, Blueprint Medicines, Celltrion, HAL Allergy, LETI Pharma, Neopharmed Gentili, and Takeda

Pricing tiers

Go-to-market motion1 record

Distribution channels6 records

Marketing channels8 records

Core offering

EAACI is a non-profit professional medical association that serves clinicians, researchers, and allied health professionals in allergy and clinical immunology. It delivers membership services, scientific congresses, peer-reviewed journals (Allergy, PAI, CTA), digital learning platforms (Nexus, Knowledge Hub), certification exams, fellowship and mentorship programmes, and clinical practice guidelines.

Product overview

EAACI is a professional medical association (European Academy of Allergy and Clinical Immunology) with over 20,000 members from 142+ countries. The organization operates as a platform-plus-events model, offering scientific journals (Allergy, PAI, CTA via Wiley partnership), digital learning platforms (EAACI Nexus, EAACI Knowledge Hub), annual and focused congresses, educational programmes (Allergy College, Knowledge Exam), mentorship and fellowship programmes, and a member portal (MyEAACI). The EAACI 3H Initiative integrates research, patient outreach, and knowledge dissemination across the allergy and clinical immunology field.

Differentiator

Problem solved

Functional benefit

Brands

• EAACI Nexus: An exclusive platform providing dynamic learning modules, EAACI event archives, and personalized programmes for career development.
• EAACI3H
• EAACI Quality Centres
• EAACI/UEMS Knowledge Exam

Products and services

• EAACI Membership Annual membership subscription for clinicians, researchers, and allied health professionals in allergy and clinical immunology. Provides access to EAACI journals, discounted event registration, EAACI Nexus learning platform, fellowship and award programmes, mentorship, and international networking.
• EAACI Annual Congress Annual flagship scientific congress bringing together allergy and clinical immunology professionals for education, networking, research presentations, scientific sessions, exhibitions, awards, and CME accreditation.
• EAACI Journals Peer-reviewed scientific journals including Allergy, Pediatric Allergy and Immunology (PAI), and Clinical and Translational Allergy (CTA), published in partnership with Wiley.
• EAACI Nexus Online learning platform providing exclusive resources including dynamic learning modules, event archives, and personalised programmes for career development of EAACI members.
• EAACI Knowledge Hub Digital knowledge repository containing consensus documents, guidelines, position papers, and educational content for allergy and immunology professionals.
• EAACI/UEMS Knowledge Exam International examination assessing comprehensive knowledge in allergology and clinical immunology with 120 multiple-choice questions, recognised for professional credentialing across Europe.
• Allergy & Winter Schools Educational events providing specialized training in specific allergy topics at various locations throughout Europe.
• EAACI Focused Meetings Focused scientific meetings on specific allergy and immunology topics such as food allergy, anaphylaxis, mast cell disorders, biological therapies, and skin allergy.
• EAACI Mentorship Programme International mentorship programme connecting Junior Members with experienced EAACI professionals for career guidance, knowledge transfer, and scientific collaboration over a two-year period.
• EAACI Fellowship Programme Awards fellowships to Junior Members and trainees for increasing knowledge and skills at European scientific institutions, with reporting requirements on outcomes.
• EAACI Quality Centres Accreditation programme recognizing healthcare centres of excellence in allergy and clinical immunology that meet EAACI quality standards.
• EAACI Events App Mobile application for accessing EAACI congress schedules, abstracts, and event information, available on Apple App Store and Google Play Store.
• MyEAACI Portal Member management portal for EAACI members to manage accounts, membership, event registration, access journals, and download certificates.
• EAACI Allergy College Educational initiative for Junior Members providing specialized training and professional development in allergy and clinical immunology.

Named customers3 records

Segments5 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

22 partnerships are on record, tiered major, core and minor.

• EU FP6 / GA²LENmajorStrategic or Co-development Partner · 1 January 2003GA²LEN (Global Allergy and Asthma European Network) was established in the EAACI office in Brussels in 2003, sponsored by EU FP6. This EU research network advances allergy and asthma research collaboration.
• 54+ National Allergy SocietiescoreStrategic or Co-development PartnerEAACI is affiliated with over 54 National Allergy Societies across Europe and globally. The NAIS Committee facilitates constant communication and collaboration on various projects and activities. These societies represent the primary national branches of EAACI in different countries.
• ALKmajorGTM or Marketing PartnerFounder sponsor of EAACI Annual Congress 2026. ALK is a pharmaceutical company specializing in allergy immunotherapy treatments.
• AstraZenecamajorGTM or Marketing PartnerFounder sponsor of EAACI Annual Congress 2026. AstraZeneca is a global pharmaceutical company with respiratory and immunology products.
• NovartismajorGTM or Marketing PartnerFounder sponsor of EAACI Annual Congress 2026. Novartis develops medicines and technologies for allergy and respiratory conditions.
• Sanofi RegeneronmajorGTM or Marketing PartnerFounder sponsor of EAACI Annual Congress 2026. Sanofi Regeneron develops Dupixent and other immunology therapies.
• GSKmajorGTM or Marketing PartnerFounder sponsor of EAACI Annual Congress 2026. GSK is a global healthcare company with respiratory and immunology portfolio.
• AllergopharmamajorGTM or Marketing PartnerFounder sponsor of EAACI Annual Congress 2026. Allergopharma specializes in allergy diagnosis and immunotherapy products.
• Allergy TherapeuticsmajorGTM or Marketing PartnerFounder sponsor of EAACI Annual Congress 2026. Allergy Therapeutics develops immunotherapies for allergies.
• CSLmajorGTM or Marketing PartnerFounder sponsor of EAACI Annual Congress 2026. CSL develops specialty biologics including immunoglobulin therapies.
• Stallergenes GreermajorGTM or Marketing PartnerFounder sponsor of EAACI Annual Congress 2026. Stallergenes Greer is a global immunotherapy company.
• DBV TechnologiesmajorGTM or Marketing PartnerFounder sponsor of EAACI Annual Congress 2026. DBV Technologies develops epicutaneous immunotherapy for food allergies.
• Blueprint MedicinesmajorGTM or Marketing PartnerFounder sponsor of EAACI Annual Congress 2026. Blueprint Medicines develops targeted therapies for severe diseases.
• CelltrionmajorGTM or Marketing PartnerFounder sponsor of EAACI Annual Congress 2026. Celltrion develops biosimilar and innovative biologic medicines.
• HAL AllergymajorGTM or Marketing PartnerFounder sponsor of EAACI Annual Congress 2026. HAL Allergy develops allergy immunotherapy products.
• LETI PharmamajorGTM or Marketing PartnerFounder sponsor of EAACI Annual Congress 2026. LETI Pharma specializes in allergy diagnosis and treatment products.
• Neopharmed GentilimajorGTM or Marketing PartnerFounder sponsor of EAACI Annual Congress 2026. Neopharmed Gentili operates in Italy with specialty pharmaceutical products.
• TakedamajorGTM or Marketing PartnerFounder sponsor of EAACI Annual Congress 2026. Takeda is a global pharmaceutical company with a focus on gastroenterology, oncology, neuroscience, and vaccines.
• WileycoreChannel Partner/ Reseller/ DistributorEAACI journals (Allergy, Pediatric Allergy and Immunology, Clinical and Translational Allergy) are published in partnership with Wiley. Members access journals through MyEAACI portal via Wiley platform.
• BnetworkminorChannel Partner/ Reseller/ DistributorOfficial hotel accommodation agent for EAACI congresses and focused meetings.
• UEMS (Union of European Medical Specialists)coreStrategic or Co-development PartnerCo-development of the EAACI/UEMS Knowledge Exam for allergology and clinical immunology certification. UEMS provides financial support opportunities for eligible candidates.
• EACCME (European Accreditation Council for Continuing Medical Education)coreStrategic or Co-development PartnerProvides CME accreditation for EAACI educational events and programs, ensuring high scientific and educational standards aligned with European and American CME systems.

Scale indicators7 records

Recent moves9 records

Expansion highlights5 records

Direct peers

• American Academy of Allergy, Asthma & Immunology: The primary US professional society for allergy and clinical immunology. Directly comparable in mission (membership, journals like JACI, annual meeting, CME, guideline-setting) and is the main counterpart to EAACI in North America.
• World Allergy Organization: Global umbrella federation of national and regional allergy/clinical immunology societies, including EAACI as a member. Comparable as an international membership body publishing the WAO Journal and running the World Allergy Congress.
• American College of Allergy, Asthma & Immunology: Second major US allergy/clinical immunology society, also publishing a peer-reviewed journal and running an annual scientific meeting. Comparable to EAACI in scale, mission, and member-base structure in North America.

Broad incumbents

• European Respiratory Society: Large European professional society covering respiratory medicine, with overlapping scope in asthma and respiratory allergy. Comparable as a European membership/education/events body serving pulmonologists, an adjacent specialty to EAACI's audience.
• European Society for Paediatric Research: European professional society for paediatric research, with overlapping membership base in paediatric allergy. Comparable in structure (European professional society, congress, journal, research grants) and in shared audience with EAACI's Pediatrics Section.
• European Society of Clinical Microbiology and Infectious Diseases: Large European clinical society running congresses (ECCMID), journals, and educational programs. Comparable as a European specialty society operating on a similar membership/events/publication model to EAACI, though in a different clinical domain.
• European Society for Medical Oncology: Leading European professional society for medical oncology, with congresses, journals, and guideline programs. Comparable to EAACI as a European specialty society with strong pharma sponsorship, congress, and guideline-setting authority, though in oncology.

Regional players

• British Society for Allergy and Clinical Immunology: UK national society for allergy and clinical immunology, affiliated with EAACI via the NAIS Committee. Comparable in offering UK-focused membership, meetings, and guidelines, but operating at a national rather than European level.
• Asia Pacific Association of Allergy, Asthma and Clinical Immunology: Regional society representing allergy/clinical immunology professionals across Asia Pacific. Comparable as a regional professional association with congresses and journals, but focused on Asia Pacific rather than Europe.
• Latin American Society of Allergy, Asthma and Immunology: Regional professional society for allergy and clinical immunology across Latin America. Comparable in mission and member offerings (congress, journal, training) but focused on a different geographic region than EAACI.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/eaaci_hq
• YouTubeyoutube.com/user/EAACIHeadquarters
• Facebookfacebook.com/eaaci
• LinkedInlinkedin.com/company/european-academy-of-allergy-and-clinical-immunology---eaaci
• Instagraminstagram.com/eaacihq

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Subsidiaries4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about European Academy of Allergy and Clinical Immunology